Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

Fecha de publicación: 28 de octubre de 2026, 10:45

Retatrutide, Eli Lilly's "triple G" injection, is still in clinical development. Kateryna Borodina/Getty Images Eli Lilly is developing a more potent weight-loss drug called retatrutide. In the first head-to-head trial versus Ozempic, retatrutide takers lost roughly twice as much weight.…